Pharmaceutical Executive-06-01-2014

Pharmaceutical Executive

What Price Innovation?

June 16, 2014

Column

0

0

Payers are seeking clear assessment of drug value to rationalize high drug prices. This issue has moved to center stage due to mounting concern over the high price for Gilead's Sovaldi, writes Jill Wechsler.